Vivien D - Search Results

1

Nicotinamide riboside, a form of vitamin B₃, protects against excitotoxicity-induced axonal degeneration.

Vaur P, Brugg B, Mericskay M, Li Z, Schmidt MS, Vivien D, Orset C, Jacotot E, Brenner C, Duplus E. Vaur P, et al. Among authors: vivien d. FASEB J. 2017 Dec;31(12):5440-5452. doi: 10.1096/fj.201700221RR. Epub 2017 Aug 21. FASEB J. 2017. PMID: 28842432

-Vaur, P., Brugg, B., Mericskay, M., Li, Z., Schmidt, M. S., Vivien, D., Orset, C., Jacotot, E., Brenner, C., Duplus, E. Nicotinamide riboside, a form of vitamin B(3), protects against excitotoxicity-induced axonal degeneration....

-Vaur, P., Brugg, B., Mericskay, M., Li, Z., Schmidt, M. S., Vivien, D., Orset, C., Jacotot, E., Brenner, C., Duplus, E. Nicot …

2

Up-regulation of a serine protease inhibitor in astrocytes mediates the neuroprotective activity of transforming growth factor beta1.

Buisson A, Nicole O, Docagne F, Sartelet H, Mackenzie ET, Vivien D. Buisson A, et al. Among authors: vivien d. FASEB J. 1998 Dec;12(15):1683-91. FASEB J. 1998. PMID: 9837858

3

Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain.

Ali C, Nicole O, Docagne F, Lesne S, MacKenzie ET, Nouvelot A, Buisson A, Vivien D. Ali C, et al. Among authors: vivien d. J Cereb Blood Flow Metab. 2000 Jun;20(6):956-66. doi: 10.1097/00004647-200006000-00008. J Cereb Blood Flow Metab. 2000. PMID: 10894179

4

Transforming growth factor alpha-induced expression of type 1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity.

Gabriel C, Ali C, Lesné S, Fernández-Monreal M, Docagne F, Plawinski L, MacKenzie ET, Buisson A, Vivien D. Gabriel C, et al. Among authors: vivien d. FASEB J. 2003 Feb;17(2):277-9. doi: 10.1096/fj.02-0403fje. Epub 2002 Dec 17. FASEB J. 2003. PMID: 12490542

5

Angiopoietin-1-induced PI3-kinase activation prevents neuronal apoptosis.

Valable S, Bellail A, Lesné S, Liot G, Mackenzie ET, Vivien D, Bernaudin M, Petit E. Valable S, et al. Among authors: vivien d. FASEB J. 2003 Mar;17(3):443-5. doi: 10.1096/fj.02-0372fje. Epub 2003 Jan 2. FASEB J. 2003. PMID: 12514118

6

The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo.

Lebeurrier N, Liot G, Lopez-Atalaya JP, Orset C, Fernandez-Monreal M, Sonderegger P, Ali C, Vivien D. Lebeurrier N, et al. Among authors: vivien d. Mol Cell Neurosci. 2005 Dec;30(4):552-8. doi: 10.1016/j.mcn.2005.09.005. Epub 2005 Oct 4. Mol Cell Neurosci. 2005. PMID: 16209928

7

Recombinant Desmodus rotundus salivary plasminogen activator crosses the blood-brain barrier through a low-density lipoprotein receptor-related protein-dependent mechanism without exerting neurotoxic effects.

López-Atalaya JP, Roussel BD, Ali C, Maubert E, Petersen KU, Berezowski V, Cecchelli R, Orset C, Vivien D. López-Atalaya JP, et al. Among authors: vivien d. Stroke. 2007 Mar;38(3):1036-43. doi: 10.1161/01.STR.0000258100.04923.84. Stroke. 2007. PMID: 17325305

8

Mouse model of in situ thromboembolic stroke and reperfusion.

Orset C, Macrez R, Young AR, Panthou D, Angles-Cano E, Maubert E, Agin V, Vivien D. Orset C, et al. Among authors: vivien d. Stroke. 2007 Oct;38(10):2771-8. doi: 10.1161/STROKEAHA.107.487520. Epub 2007 Aug 16. Stroke. 2007. PMID: 17702959

9

Selective inhibition of GluN2D-containing N-methyl-D-aspartate receptors prevents tissue plasminogen activator-promoted neurotoxicity both in vitro and in vivo.

Jullienne A, Montagne A, Orset C, Lesept F, Jane DE, Monaghan DT, Maubert E, Vivien D, Ali C. Jullienne A, et al. Among authors: vivien d. Mol Neurodegener. 2011 Oct 5;6:68. doi: 10.1186/1750-1326-6-68. Mol Neurodegener. 2011. PMID: 21975018 Free PMC article.

10

Thrombotic stroke in the anesthetized monkey (Macaca mulatta): characterization by MRI--a pilot study.

Gauberti M, Obiang P, Guedin P, Balossier A, Gakuba C, Diependaele AS, Chazalviel L, Vivien D, Young AR, Agin V, Orset C. Gauberti M, et al. Among authors: vivien d. Cerebrovasc Dis. 2012;33(4):329-39. doi: 10.1159/000335309. Epub 2012 Feb 16. Cerebrovasc Dis. 2012. PMID: 22343114

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

340 results

Search Page